Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IceCure Medical (ICCM) Operating Leases (2020 - 2025)

IceCure Medical (ICCM) has disclosed Operating Leases for 6 consecutive years, with $217000.0 as the latest value for Q4 2025.

  • Quarterly Operating Leases fell 52.72% to $217000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $217000.0 through Dec 2025, down 52.72% year-over-year, with the annual reading at $217000.0 for FY2025, 52.72% down from the prior year.
  • Operating Leases for Q4 2025 was $217000.0 at IceCure Medical, down from $459000.0 in the prior quarter.
  • The five-year high for Operating Leases was $685000.0 in Q4 2021, with the low at $217000.0 in Q4 2025.
  • Average Operating Leases over 5 years is $478000.0, with a median of $459000.0 recorded in 2024.
  • The sharpest move saw Operating Leases skyrocketed 480.51% in 2021, then tumbled 52.72% in 2025.
  • Over 5 years, Operating Leases stood at $685000.0 in 2021, then plummeted by 37.23% to $430000.0 in 2022, then soared by 39.3% to $599000.0 in 2023, then dropped by 23.37% to $459000.0 in 2024, then crashed by 52.72% to $217000.0 in 2025.
  • According to Business Quant data, Operating Leases over the past three periods came in at $217000.0, $459000.0, and $599000.0 for Q4 2025, Q4 2024, and Q4 2023 respectively.